Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-02-03 @ 9:51 AM
Study NCT ID:
NCT05770466
Status:
COMPLETED
Last Update Posted:
2024-04-16
First Post:
2022-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.
Sponsor:
National Taiwan University Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | COVID-19 | View |
Keywords: